Cancer Rop Co. Ltd. (180400.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea · ISIN KR7180400004

Price
2,065.00 KRW
Market cap
203.26 bn KRW
P/E (2025)
–
P/S (2025)
6.92
Dividend yield
0.00 %
Net margin
-98.92 %
Return on equity (ROE)
-30.91 %
Return on assets (ROA)
-18.75 %

Cancer Rop Co. Ltd. financials

Fiscal year20242025
Revenue33.95 bn KRW29.36 bn KRW
Gross profit5.14 bn KRW3.32 bn KRW
Operating income-21.60 bn KRW-24.32 bn KRW
EBIT-51.12 bn KRW-29.19 bn KRW
Net income-47.03 bn KRW-29.04 bn KRW
Diluted EPS – continuing operations–-295.03 KRW

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Cancer Rop Co. Ltd.

Dx & Vx Co., Ltd. engages in the development and sale of bio-health care products and provides molecular genetic testing services primarily in South Korea. The company offers healthcare products, including Ofmom Carefree, oat fermented food, and biocleaners; diagnostic products, comprising CLIDEX, precision diagnostics, and in vitro diagnostic kit; health check services; CDx development services; medical data; and funeral home operation services. It provides bacterial vaccine for respiratory disease; macular degeneration drug; atopy dermatitis drugs; xeropthalmia drugs; anticancer vaccine; and new antibody drugs. Its pipeline includes Vx product, oral pediatric Covid19/influenza vaccine; new anti-cancer antibody drug; an antibody drug utilizing advanced mRNA vaccine development technique; Vx Microbiome R&D pipeline, a bacterial vaccine against respiratory diseases, new drugs targeting obesity and diagnosis etc; and Oxford Vacmedix Vaccine, an anti-cancer vaccineutilizing ROP technology. It has a research collaboration with bereum, Bioapp, CORESTEMCHEMON, Genscript PROBIO, JOINTOWN PHARMACEUTICAL GROUP,etc. The company was formerly known as Cancer Rop Co., Ltd. and changed its name to Dx & Vx Co., Ltd. in January 2022. The company was founded in 2001 and is based in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.